These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19179271)

  • 1. Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes.
    Biasucci LM; Liuzzo G; Della Bona R; Leo M; Biasillo G; Angiolillo DJ; Abbate A; Rizzello V; Niccoli G; Giubilato S; Crea F
    Clin Chem; 2009 Feb; 55(2):365-8. PubMed ID: 19179271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina.
    Niccoli G; Biasucci LM; Biscione C; Fusco B; Porto I; Leone AM; Bona RD; Dato I; Liuzzo G; Crea F
    Atherosclerosis; 2008 Feb; 196(2):779-85. PubMed ID: 17306806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome.
    Kaski JC; Consuegra-Sanchez L; Fernandez-Berges DJ; Cruz-Fernandez JM; Garcia-Moll X; Marrugat J; Mostaza J; Toro-Cebada R; González-Juanatey JR; Guzmán-Martínez G;
    Atherosclerosis; 2008 Nov; 201(1):176-83. PubMed ID: 18336825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion.
    Ma QQ; Yang XJ; Yang NQ; Liu L; Li XD; Zhu K; Fu Q; Wei P
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4294-4298. PubMed ID: 27831644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction.
    Hashimoto T; Ishii J; Kitagawa F; Yamada S; Hattori K; Okumura M; Naruse H; Motoyama S; Matsui S; Tanaka I; Izawa H; Maruyama I; Nomura M; Ozaki Y
    Atherosclerosis; 2012 Apr; 221(2):490-5. PubMed ID: 22369934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-9 index as a possible parameter for predicting acute coronary syndrome in diabetics.
    Popović S; Canović F; Ilić M; Rafajlovski S; Dimitrijević-Srećović V; Matanović D; Vujović S; Djordjević P; Gostiljac D
    Vojnosanit Pregl; 2015 May; 72(5):421-6. PubMed ID: 26165049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes.
    Çoner A; Aydınalp A; Müderrisoğlu H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):96-103. PubMed ID: 30961517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease.
    Sentürk T; Cordan J; Baran I; Ozdemir B; Güllülü S; Aydinlar A; Göral G
    Acta Cardiol; 2007 Apr; 62(2):135-41. PubMed ID: 17536601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus.
    Fu Z; Xue H; Guo J; Chen L; Dong W; Gai L; Liu H; Sun Z; Chen Y
    Cardiovasc Diabetol; 2013 Nov; 12():157. PubMed ID: 24182196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.
    Heeschen C; Hamm CW; Bruemmer J; Simoons ML
    J Am Coll Cardiol; 2000 May; 35(6):1535-42. PubMed ID: 10807457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
    Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
    Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome.
    Ma P; Han L; Lv Z; Chen W; Hu H; Tu J; Zhou X; Liu SM
    BMC Cardiovasc Disord; 2016 Feb; 16():29. PubMed ID: 26830193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.
    Chan CY; Li R; Chan JY; Zhang Q; Chan CP; Dong M; Yan BP; Lam YY; Yu CM
    Clin Cardiol; 2011 Aug; 34(8):507-12. PubMed ID: 21717470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome.
    Lillpopp L; Tzikas S; Ojeda F; Zeller T; Baldus S; Bickel C; Sinning CR; Wild PS; Genth-Zotz S; Warnholtz A; Lackner KJ; Münzel T; Blankenberg S; Keller T
    Am J Cardiol; 2012 Nov; 110(9):1225-30. PubMed ID: 22818785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.
    Arroyo-Espliguero R; Avanzas P; Quiles J; Kaski JC
    Atherosclerosis; 2009 May; 204(1):239-43. PubMed ID: 18823889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.